ClearRx
Trademark for drug bottle design
ClearRx is a trademark for a design for prescription drug packaging, designed by design student Deborah Adler as a thesis project and adopted by Target Corporation (with refinements by industrial designer Klaus Rosburg) for use in their in-store pharmacies in 2005. The design is an attempt to clarify certain challenging aspects common to most prescription bottles used in the US.
Background
The ClearRx bottle design was created to replace the classic orange pill bottle, which had existed since just after World War II. Patients often did not read the information on the orange bottle label, as the text was tiny, and the company logo was usually the most emphasized text on the bottle. Warnings and cautions were also printed in inadequate color combinations, making them hard to read.
Design
Bottles have a distinctive rounded-wedge shape and are designed to stand on their caps, with the label folding over the top of the bottle, where the name of the drug is printed in large print for easy identification. A cutout on the back of the bottle includes space for a data card describing the effects and risks of the medication. Fundamental to the design is a colored rubber ring that serves as a color code so different household members can distinguish their prescriptions. An overall priority is given to distinguishability; the most important information (patient name, drug name, instructions) is placed prominently on the upper half of the label. Other innovations include revised warning symbols and labels and a small magnifying strip that can be inserted into the side of the bottle for customers with visual impairments.
Liquid medicine bottles are not quite as distinctive, but they feature a spill-proof cap coupled with a dosing syringe that is claimed to be more accurate than spoon dispensing. The liquid medicine bottles also feature a color-coded ring around the neck.
This brief starts where responsible research should: with the source description of “ClearRx” as trademark for drug bottle design. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as trademark for drug bottle design. Its deeper value depends on whether names, dates, institutions and citations support that framing.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Aug 13, 2024. The linked authority identifier is Q5130625. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2005.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “ClearRx”, its source revision and the description used here.
- Expand the search: follow ClearRx primary sources, ClearRx archive and ClearRx research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “ClearRx”?
- Which institution is responsible for the underlying evidence?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “ClearRx” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.